Home › Compare › BMCS vs RYLD

BMCS vs RYLD: Dividend Comparison 2026

BMCS yields 181818.18% · RYLD yields 12.39%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMCS wins by $1.8951031795759825e+29M in total portfolio value
10 years
BMCS
BMCS
● Live price
181818.18%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8951031795759825e+29M
Annual income
$189,305,502,041,192,720,000,000,000,000,000,000.00
Full BMCS calculator →
RYLD
RYLD
● Live price
12.39%
Share price
$14.64
Annual div
$1.81
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.3K
Annual income
$2,682.98
Full RYLD calculator →

Portfolio growth — BMCS vs RYLD

📍 BMCS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMCSRYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMCS + RYLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BMCS pays
RYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMCS
Annual income on $10K today (after 15% tax)
$15,454,545.45/yr
After 10yr DRIP, annual income (after tax)
$160,909,676,735,013,800,000,000,000,000,000,000.00/yr
RYLD
Annual income on $10K today (after 15% tax)
$1,053.44/yr
After 10yr DRIP, annual income (after tax)
$2,280.53/yr
At 15% tax rate, BMCS beats the other by $160,909,676,735,013,800,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMCS + RYLD for your $10,000?

BMCS: 50%RYLD: 50%
100% RYLD50/50100% BMCS
Portfolio after 10yr
$9.475515897879912e+28M
Annual income
$94,652,751,020,596,360,000,000,000,000,000,000.00/yr
Blended yield
99.89%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMCS buys
0
RYLD buys
0
No recent congressional trades found for BMCS or RYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMCSRYLD
Forward yield181818.18% ✓12.39%
Annual dividend / share$2.00 ✓$1.81
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$1.8951031795759825e+29M$45.3K ✓
Annual income after 10y$189,305,502,041,192,720,000,000,000,000,000,000.00 ✓$2,682.98
Total dividends collected$1.8949690612486723e+29M$19.4K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: BMCS vs RYLD ($10,000, DRIP)

YearBMCS PortfolioBMCS Income/yrRYLD PortfolioRYLD Income/yrGap
1← crossover$18,192,518$18,181,818.18$11,939$1,239.34+$18.18M → BMCS
2$30,932,835,887$30,913,369,892.64$14,158$1,382.89+$30932.82M → BMCS
3$49,156,619,660,049$49,123,521,525,649.34$16,682$1,532.59+$49156619.64M → BMCS
4$73,009,768,971,452,110$72,957,171,388,415,860.00$19,537$1,687.64+$73009768971.43M → BMCS
5$101,348,671,691,011,770,000$101,270,551,238,212,300,000.00$22,752$1,847.20+$101348671691011.75M → BMCS
6$131,490,628,941,834,950,000,000$131,382,185,863,125,600,000,000.00$26,355$2,010.43+$131490628941834960.00M → BMCS
7$159,445,709,700,484,420,000,000,000$159,305,014,727,516,640,000,000,000.00$30,376$2,176.45+$159445709700484431872.00M → BMCS
8$180,706,560,655,892,340,000,000,000,000$180,535,953,746,512,850,000,000,000,000.00$34,847$2,344.43+$1.8070656065589233e+23M → BMCS
9$191,416,744,304,199,340,000,000,000,000,000$191,223,388,284,297,560,000,000,000,000,000.00$39,800$2,513.54+$1.9141674430419936e+26M → BMCS
10$189,510,317,957,598,240,000,000,000,000,000,000$189,305,502,041,192,720,000,000,000,000,000,000.00$45,269$2,682.98+$1.8951031795759825e+29M → BMCS

BMCS vs RYLD: Complete Analysis 2026

BMCS — Stock

BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida.

Full BMCS Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →
📬

Get this BMCS vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMCS vs SCHDBMCS vs JEPIBMCS vs OBMCS vs KOBMCS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.